Publication | Closed Access

Targeted therapy against chemoresistant colorectal cancers: Inhibition of p38α modulates the effect of cisplatin in vitro and in vivo through the tumor suppressor FoxO3A

OncologyTumor Suppressor Foxo3aMedicineColorectal CancerCancer Cell BiologyAnti-cancer AgentCancer TreatmentChemoresistant Colorectal CancersPharmacologyCell BiologyCancer ResearchTumor Biology